Facebook
Twitter
Telegram
Report an ErrorBlack Diamond Therapeutics Financial Statements 2011-2024 | BDTX
Annual Financial Statements Black Diamond Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
166 M | 54.5 M | 193 M | 890 M | 1.29 B | - | - | - | - | - | - | - | - |
Shares |
44 M | 36.3 M | 36.2 M | 35.9 M | 32.6 M | - | - | - | - | - | - | - | - |
Historical Prices |
3.78 | 1.5 | 5.33 | 32 | - | - | - | - | - | - | - | - | - |
Net Income |
-82.4 M | -91.2 M | -126 M | -67.3 M | -35.3 M | -8.93 M | -4.6 M | - | - | - | - | - | - |
Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-86.5 M | -92.8 M | -127 M | -69.6 M | -29.3 M | -8.9 M | - | - | - | - | - | - | - |
Interest Expense |
2.09 M | -354 K | -2.19 M | 1 K | - | -16 K | - | - | - | - | - | - | - |
EBITDA |
-86 M | -92.3 M | -127 M | -67.2 M | -22.9 M | -8.87 M | -4.1 M | - | - | - | - | - | - |
Operating Expenses |
86.5 M | 92.8 M | 127 M | 69.6 M | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
27.1 M | 28.4 M | 30 M | 21.4 M | 7.58 M | 1.95 M | 666 K | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement Black Diamond Therapeutics
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
50.9 M | 36.5 M | 36.5 M | 36.4 M | 36.3 M | 36.3 M | 36.3 M | 36.2 M | 36.2 M | 36.2 M | 36.1 M | 36.1 M | 35.9 M | 35.9 M | 23.7 M | 2.24 M | 2.07 M | 2.05 M | 2.04 M | 2.17 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-23 M | -19.2 M | -20.9 M | - | -21.7 M | -22.9 M | -25.5 M | - | -35.1 M | -34.4 M | -30.3 M | -22.6 M | -17.9 M | -14.6 M | -12.1 M | -9.88 M | -9.27 M | -12.3 M | -3.83 M | -3.07 M | -2.36 M | -1.91 M | -1.59 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-24 M | -20 M | -21.6 M | - | -22.1 M | -23.2 M | -25.7 M | - | -35.4 M | -34.7 M | -30.7 M | -23.2 M | -18.5 M | -15 M | -12.9 M | -10.3 M | -8.15 M | -7 M | -3.84 M | -3.05 M | -2.34 M | -1.91 M | -1.6 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
566 K | 341 K | 64 K | - | -92 K | -143 K | -234 K | - | -489 K | -584 K | -740 K | - | - | 1 K | -10 K | - | - | - | 2 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
- | - | -21.4 M | - | -21.7 M | -22.9 M | -25.6 M | - | -35.3 M | -34.7 M | -30.7 M | -23.2 M | -18.4 M | -15 M | -12.9 M | -10.3 M | -8.11 M | -6.97 M | -3.83 M | -3.05 M | -2.34 M | -1.91 M | -1.6 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
24 M | 20 M | 21.6 M | - | 22.1 M | 23.2 M | 25.7 M | - | 35.4 M | 34.7 M | 30.7 M | 23.2 M | 18.5 M | 15 M | 12.9 M | 10.3 M | 8.15 M | 7 M | 3.84 M | 3.05 M | 2.34 M | 1.91 M | 1.6 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
7.86 M | 6.88 M | 6.81 M | - | 6.28 M | 6.98 M | 7.89 M | - | 7.74 M | 8 M | 7.89 M | - | 5.55 M | 4.86 M | 5.52 M | - | 2.51 M | 1.35 M | 828 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency